1 Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France. maud.kamal@curie.fr.
2 Department of Drug Development and Innovation, Institut Curie, PSL Research University, 92210, Saint-Cloud, France. maud.kamal@curie.fr.
3 Institut Curie, Genomics of Excellence (ICGex) Platform, PSL Research University, 75005, Paris, France.
4 Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.
5 Department of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
6 Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
7 Department of Drug Development and Innovation, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
8 Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France.
9 Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
10 Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
11 Department of Medical Oncology, Erasmus MC, 3000 CA, Rotterdam, The Netherlands.
12 Oncology Institute of Vojvodina, Put doktora Goldmana, 421204, Sremska Kamenica, Serbia.
13 Department of Surgery, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
14 Paris-Saclay University, Paris, France.
15 Hopital Privé Pays de Savoie, Service d'oncologie médicale, 19 avenue Pierre Mendès France, 74100, Annemasse, France.
16 Institut Curie, PSL Research University, CNRS UMR3244, 75248, Paris, France.
17 Faculty of Pharmaceutical and Biological Sciences, INSERM U1016, Paris Descartes University, 75005, Paris, France.